These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3969371)

  • 1. Heterogeneity of steroid binding sites in prostatic carcinoma: morphological demonstration and clinical implications.
    Pertschuk LP; Eisenberg KB; Macchia RJ; Feldman JG
    Prostate; 1985; 6(1):35-47. PubMed ID: 3969371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histochemical analyses of steroid hormone receptors in breast and prostatic carcinoma.
    Pertschuk LP; Tobin EH; Tanapat P; Gaetjens E; Carter AC; Bloom ND; Macchia RJ; Eisenberg KB
    J Histochem Cytochem; 1980 Aug; 28(8):799-810. PubMed ID: 7440959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemistry of steroid receptors in prostatic diseases.
    Pertschuk LP; Zava DT; Gaetjens E; Macchia RJ; Wise GJ; Kim DS; Brigati DJ
    Ann Clin Lab Sci; 1979; 9(3):225-9. PubMed ID: 380450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic assay of steroid hormone receptors in human neoplasia.
    Pertschuk LP; Tobin EH; Brigati DJ; Gaetjens E
    Pathol Annu; 1980; 15(Pt 2):143-80. PubMed ID: 6161331
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical applications and value of receptor levels in treatment of prostate cancer.
    Connolly JG; Mobbs BG
    Prostate; 1984; 5(5):477-83. PubMed ID: 6384975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
    Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of estrogen, androgen and progestogen receptors in the management of carcinoma of the prostate.
    Young JD; Sidh SM; Bashirelahi N
    Trans Am Assoc Genitourin Surg; 1979; 71():23-5. PubMed ID: 545809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.
    Shain SA; Boesel RW
    Invest Urol; 1978 Nov; 16(3):169-74. PubMed ID: 361632
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: relation to therapeutic response.
    Pertschuk LP; Rosenthal HE; Macchia RJ; Eisenberg KB; Feldman JG; Wax SH; Kim DS; Whitmore WF; Abrahams JI; Gaetjens E; Wise GJ; Herr HW; Karr JP; Murphy GP; Sandberg AA
    Cancer; 1982 Mar; 49(5):984-93. PubMed ID: 7059932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional steroid receptors in prostatic carcinoma. A comparison between viable cell assay and fluorescent staining method].
    Umehara T; Takagi Y; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1988 Dec; 79(12):1937-46. PubMed ID: 3230744
    [No Abstract]   [Full Text] [Related]  

  • 11. Androgen receptor assays in advanced prostatic cancer.
    Buttyan R; Olsson CA
    Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer.
    Trachtenberg J; Walsh PC
    J Urol; 1982 Mar; 127(3):466-71. PubMed ID: 7062420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].
    Bassalyk LS; Petrova AS; Ermilova VD; Sokolova VK; Kushlinskiĭ NE
    Arkh Patol; 1983; 45(2):23-8. PubMed ID: 6847409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor.
    Heston WD; Menon M; Tananis C; Walsh PC
    Cancer Lett; 1979 Jan; 6(1):45-50. PubMed ID: 544011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent androgen derivatives do not discriminate between androgen receptor-positive and -negative human tumor cell lines.
    Berns EM; Mulder E; Rommerts FF; van der Molen HJ; Blankenstein RA; Bolt-de Vries J; de Goeij TF
    Prostate; 1984; 5(4):425-37. PubMed ID: 6739374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen binding in prostatic carcinoma by histochemistry: update 1985.
    Pertschuk LP; Macchia RJ
    Appl Pathol; 1985; 3(4):221-9. PubMed ID: 3842264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of androgen and estrogen receptors in human prostatic carcinoma and hyperplasia by fluorescence microscopy.
    Pertschuk LP; Zava DT; Gaetjens E; Macchia RJ; Brigati DJ; Kim DS
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):427-30. PubMed ID: 569892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptors in human prostatic cancer a preliminary evaluation.
    de Voogt HJ; Dingjan P
    Urol Res; 1978; 6(3):151-8. PubMed ID: 81556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Correlation with conventional biochemical assays.
    Curtin CT; Pertschuk LP; Mitchell V
    Acta Cytol; 1982; 26(6):841-6. PubMed ID: 6961721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.